Company Data

Sigyn Therapeutics Inc

Ticker
SIGY
Current Price
$0.2498
Market Cap
$9.3M
Price Target
Refer to Report
52wk Range
$0.146 - $0.73
Advanced Market Data

Overview

Sigyn Therapeutics Inc is a development-stage therapeutic technology company. Its focus is directed toward a unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Sigyn Therapy is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a cause of SARS-CoV-2 (COVID-19) deaths.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.